Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab with Radiation and Cisplatin in Stage III/IV Head and Neck Cancer
NCT00265941Phase 3Completed
- Sponsor
- NRG Oncology
- Start
- Nov 2005
- Primary completion
- Jan 2011
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 3 trial of KL-140 in head and neck squamous cell carcinoma (HNSCC), sponsored by NRG Oncology. Started Nov 2005; status: completed.
02
Drugs
KL-140
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00265941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00265941.